Literature DB >> 29437803

Nasopharyngeal angiofibroma in a 32-year-old man.

Patrick O McGarey1, Abel P David2, Spencer C Payne1.   

Abstract

Nasopharyngeal angiofibroma (NA) is a benign, highly vascularised tumour of the nasopharynx, which typically occurs in young males aged 14-25 years. We report an interesting case of an NA arising de novo in a 32-year-old male. He was referred to our facility for severe nasal haemorrhage after biopsy of a left nasopharyngeal mass. In the operating room, extensive bleeding was noted, and an endoscopic medial maxillectomy was performed, and the left internal maxillary artery was ligated allowing for near total resection of the lesion. The pathological specimen confirmed the diagnosis of NA. To our knowledge, this is one of the oldest patients presenting with a de novo NA, in his fourth decade of life, confirming that this diagnosis must be considered in all those with large nasopharyngeal masses. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  ear, nose and throat/otolaryngology; head and neck cancer

Mesh:

Year:  2018        PMID: 29437803      PMCID: PMC5836611          DOI: 10.1136/bcr-2017-222763

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

1.  Atypical angiofibromas: a report of four cases.

Authors:  Bilge Celik; Levent Erisen; Ozlem Saraydaroglu; Hakan Coskun
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2004-12-28       Impact factor: 1.675

2.  A new endoscopic staging system for angiofibromas.

Authors:  Carl H Snyderman; Harshita Pant; Ricardo L Carrau; Paul Gardner
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-06

3.  Flutamide as a preoperative treatment in juvenile angiofibroma (JA) with intracranial invasion: report of 7 cases.

Authors:  Alberto Labra; Rogelio Chavolla-Magaña; Adriana Lopez-Ugalde; Jorge Alanis-Calderon; Angel Huerta-Delgado
Journal:  Otolaryngol Head Neck Surg       Date:  2004-04       Impact factor: 3.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.